BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8846245)

  • 1. Communicating pharmaceutical outcomes to hospital administration.
    Mountzuris J
    Am J Health Syst Pharm; 1995 Oct; 52(19 Suppl 4):S9-11. PubMed ID: 8846245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating pharmacoeconomic principles into hospital pharmacy practice.
    Gouveia WA; Bungay KM
    Top Hosp Pharm Manage; 1994 Jan; 13(4):31-7. PubMed ID: 10130681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of psychiatric pharmacists.
    Cohen LJ
    Am J Manag Care; 1999 Jul; 5(10 Suppl):S621-9; quiz S630-3. PubMed ID: 10539497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods to assess the economic outcomes of clinical pharmacy services.
    Schumock GT
    Pharmacotherapy; 2000 Oct; 20(10 Pt 2):243S-252S. PubMed ID: 11034050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical care and patient outcomes: notes on what it is we manage.
    Strand LM
    Top Hosp Pharm Manage; 1990 Aug; 10(2):77-84. PubMed ID: 10128568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical care: pharmacy's mission for the 1990s.
    Penna RP
    Am J Hosp Pharm; 1990 Mar; 47(3):543-9. PubMed ID: 2316539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomics and the formulary decision-making process.
    Bakst A
    Hosp Formul; 1995 Jan; 30(1):42-50. PubMed ID: 10172201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoeconomics: therapeutic and economic considerations in treating the critically ill patient.
    Crane VS
    DICP; 1990 Nov; 24(11 Suppl):S24-7. PubMed ID: 2125394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing comprehensive pharmaceutical services at an academic tertiary care hospital.
    Janning SW; Stevenson JG; Smolarek RT
    Am J Health Syst Pharm; 1996 Mar; 53(5):542-7. PubMed ID: 8697014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving care transitions: current practice and future opportunities for pharmacists.
    ; Hume AL; Kirwin J; Bieber HL; Couchenour RL; Hall DL; Kennedy AK; LaPointe NM; Burkhardt CD; Schilli K; Seaton T; Trujillo J; Wiggins B
    Pharmacotherapy; 2012 Nov; 32(11):e326-37. PubMed ID: 23108810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial management of hospital pharmacies.
    Nold EG
    Am J Hosp Pharm; 1983 Aug; 40(8):1339-41. PubMed ID: 6614019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluations of clinical pharmacy services: 2006-2010.
    Touchette DR; Doloresco F; Suda KJ; Perez A; Turner S; Jalundhwala Y; Tangonan MC; Hoffman JM
    Pharmacotherapy; 2014 Aug; 34(8):771-93. PubMed ID: 24644086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future pharmacy initiatives in institutional and corporate practice.
    Oddis JA
    Am J Hosp Pharm; 1984 Feb; 41(2):279-84. PubMed ID: 6702832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling financial variables--changing prescribing patterns.
    Abramowitz PW
    Am J Hosp Pharm; 1984 Mar; 41(3):503-15. PubMed ID: 6367444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turbulence and tranquility in the new decade: pharmacy leader--managers in patient care.
    Gouveia WA
    Am J Hosp Pharm; 1990 Feb; 47(2):311-9. PubMed ID: 2309717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing the rules of the reimbursement game.
    Curtiss FR
    Am J Hosp Pharm; 1982 Nov; 39(11):1975-7. PubMed ID: 7148872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A commentary on high-cost drugs.
    de Leon RF
    Curr Concepts Hosp Pharm Manage; 1989; 11(3):4-7. PubMed ID: 10318277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacy component of a hospital end-product cost-accounting system.
    Smith JE; Sheaffer SL; Meyer GE; Giorgilli F
    Am J Hosp Pharm; 1988 Apr; 45(4):835-43. PubMed ID: 3376968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.